HOPE GREGORY: Open Payments
NPI 1912348244 · NORTHVILLE, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$223 in 10 payments from 6 companies in 2025. Trend: 2023 $631 · 2024 $194 · 2025 $223
Food & beverage: $223
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $62 |
| ABBVIE INC. | 2 | $52 |
| Astellas Pharma US Inc | 2 | $48 |
| Dexcom, Inc. | 1 | $25 |
| GlaxoSmithKline, LLC. | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
Products named: UBRELVY, Veozah, AIRSUPRA, Dexcom G6 Transmitter, TRELEGY ELLIPTA, BREZTRI, SEROQUEL, REXULTI.
Industry payments across MI — which companies pay providers there.
